Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations

BACKGROUND: Plasma circulating tumor DNA (ctDNA) may be a surrogate, minimally invasive approach to tissue-based epidermal growth factor receptor (EGFR) mutation detection in non-small cell lung cancer (NSCLC) patients. However, the predictive ability of preoperative ctDNA EGFR mutation test on long...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Kai, Shao, Changjian, Han, Lu, Liu, Honggang, Ma, Zhiqiang, Yang, Yang, Feng, Yingtong, Pan, Minghong, Santarpia, Mariacarmela, Carmo-Fonseca, Maria, Silveira, Catarina, Lee, Kye Young, Han, Jing, Li, Xiaofei, Yan, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350110/
https://www.ncbi.nlm.nih.gov/pubmed/34430359
http://dx.doi.org/10.21037/tlcr-21-530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350110/
https://www.ncbi.nlm.nih.gov/pubmed/34430359
http://dx.doi.org/10.21037/tlcr-21-530

Ejemplares similares